Alex G. Segura , Norma Verdolini , Isabel Valli , Clemente Garcia-Rizo , Covadonga M. Diaz-Caneja , Eduard Vieta , Gisela Mezquida , Antonio Lobo , Ana Gonzalez-Pinto , Álvaro Andreu-Bernabeu , Alejandra Roldan , Anabel Martinez-Aran , Inmaculada Baeza , Anna Mane , Javier Labad , Daniel J. Müller , Nora Guasch-Capella , Miquel Bernardo , Sergi Mas , PEPs Group, Manuel J. Cuesta
{"title":"Polygenic risk score of glycemic homeostasis, Type 2 Diabetes Mellitus and glycemic components in first episode psychosis","authors":"Alex G. Segura , Norma Verdolini , Isabel Valli , Clemente Garcia-Rizo , Covadonga M. Diaz-Caneja , Eduard Vieta , Gisela Mezquida , Antonio Lobo , Ana Gonzalez-Pinto , Álvaro Andreu-Bernabeu , Alejandra Roldan , Anabel Martinez-Aran , Inmaculada Baeza , Anna Mane , Javier Labad , Daniel J. Müller , Nora Guasch-Capella , Miquel Bernardo , Sergi Mas , PEPs Group, Manuel J. Cuesta","doi":"10.1016/j.schres.2025.09.019","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>First episode of psychosis (FEP) is associated with glucose homeostasis abnormalities even before pharmacological intervention. Given inconclusive GWAS results regarding a direct genetic link between schizophrenia and type 2 diabetes mellitus (T2DM), we hypothesized that FEP patients may exhibit altered genetic risk for glycemic traits. We compared polygenic risk scores (PRS) for T2DM (PRS<sub>T2DM</sub>), fasting glucose (PRS<sub>FG</sub>), and glycated hemoglobin (HbA1c) (PRS<sub>HbA1c</sub>) between FEP patients and controls, examining their associations with glycemic measures over 24 months.</div></div><div><h3>Methods</h3><div>We analyzed data from 242 FEP patients and 119 controls, assessing fasting serum glucose and HbA1c at baseline and 24 months. We examined cross-sectional and longitudinal associations between PRS and glycemic measures within each group.</div></div><div><h3>Results</h3><div>FEP patients and controls did not differ significantly in PRS. Significant associations were observed for PRS<sub>FG</sub> with baseline serum glucose in controls (<em>p</em> = 0.008), PRS<sub>FG</sub> during follow-up (<em>p</em> = 0.034), PRS<sub>HbA1c</sub> at 24 months (<em>p</em> = 0.018), and HbA1c longitudinally (<em>p</em> = 0.025). After multiple testing corrections, only the association between PRS<sub>FG</sub> and baseline serum glucose in controls remained significant (p_adj = 0.023). No associations were found for PRS<sub>T2DM.</sub></div></div><div><h3>Conclusions</h3><div>Despite the link between FEP and glycemic disturbances, PRS<sub>T2DM</sub> did not differ between FEP patients and controls. However, PRS for glycemic traits showed associations with glycemic measures in both groups before multiple testing correction, suggesting that genetic predisposition may influence glucose homeostasis in early psychosis. The absence of a direct association between common genetic variants underlying T2DM and early glycemic dysregulation in FEP underscores the importance of considering environmental factors and epigenetic mechanisms.</div></div>","PeriodicalId":21417,"journal":{"name":"Schizophrenia Research","volume":"285 ","pages":"Pages 265-275"},"PeriodicalIF":3.5000,"publicationDate":"2025-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Schizophrenia Research","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0920996425003299","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective
First episode of psychosis (FEP) is associated with glucose homeostasis abnormalities even before pharmacological intervention. Given inconclusive GWAS results regarding a direct genetic link between schizophrenia and type 2 diabetes mellitus (T2DM), we hypothesized that FEP patients may exhibit altered genetic risk for glycemic traits. We compared polygenic risk scores (PRS) for T2DM (PRST2DM), fasting glucose (PRSFG), and glycated hemoglobin (HbA1c) (PRSHbA1c) between FEP patients and controls, examining their associations with glycemic measures over 24 months.
Methods
We analyzed data from 242 FEP patients and 119 controls, assessing fasting serum glucose and HbA1c at baseline and 24 months. We examined cross-sectional and longitudinal associations between PRS and glycemic measures within each group.
Results
FEP patients and controls did not differ significantly in PRS. Significant associations were observed for PRSFG with baseline serum glucose in controls (p = 0.008), PRSFG during follow-up (p = 0.034), PRSHbA1c at 24 months (p = 0.018), and HbA1c longitudinally (p = 0.025). After multiple testing corrections, only the association between PRSFG and baseline serum glucose in controls remained significant (p_adj = 0.023). No associations were found for PRST2DM.
Conclusions
Despite the link between FEP and glycemic disturbances, PRST2DM did not differ between FEP patients and controls. However, PRS for glycemic traits showed associations with glycemic measures in both groups before multiple testing correction, suggesting that genetic predisposition may influence glucose homeostasis in early psychosis. The absence of a direct association between common genetic variants underlying T2DM and early glycemic dysregulation in FEP underscores the importance of considering environmental factors and epigenetic mechanisms.
期刊介绍:
As official journal of the Schizophrenia International Research Society (SIRS) Schizophrenia Research is THE journal of choice for international researchers and clinicians to share their work with the global schizophrenia research community. More than 6000 institutes have online or print (or both) access to this journal - the largest specialist journal in the field, with the largest readership!
Schizophrenia Research''s time to first decision is as fast as 6 weeks and its publishing speed is as fast as 4 weeks until online publication (corrected proof/Article in Press) after acceptance and 14 weeks from acceptance until publication in a printed issue.
The journal publishes novel papers that really contribute to understanding the biology and treatment of schizophrenic disorders; Schizophrenia Research brings together biological, clinical and psychological research in order to stimulate the synthesis of findings from all disciplines involved in improving patient outcomes in schizophrenia.